Delivery Order SPE2DB22D1017-SPE2DB24FG1KH

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,978.20 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a $18,091.57 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of PREVNAR 20 SYRINGE 0.5ML, a vaccine product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The $4,787.28 firm fixed price contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal conjugate vaccine. This order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities...
This is a $5,296.64 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, which is a pneumococcal vaccine. The award has an ultimate completion date of February 20, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,216.33 contract is for the supply of PREVNAR 20 syringes, a vaccine against pneumococcal disease. The order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $4,807.08 firm-fixed-price contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $25,557.20 firm-fixed-price contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine, to support military treatment facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp. The $3,031.56 contract is for the supply of PREVNAR 20 SYRINGE 0.5ML pharmaceutical products. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
This is a $7,818.23 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,409.48 contract is for the delivery of PREVNAR 20 syringe 0.5ML, a pneumococcal vaccine, with a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG1KH
    Delivery Order

This $4,787.28 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of PREVNAR 20 SYRINGE 0.5ML, which is a pneumococcal vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a period of performance through December 2025 and does not have a set-aside designation.

Generated 10/15/24, 9:40 PM